000 01330 a2200385 4500
005 20250512134006.0
264 0 _c19711008
008 197110s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(69)90375-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHaskell, C M
245 0 0 _al-asparaginase resistance in human leukemia--asparagine synthetase.
_h[electronic resource]
260 _bBiochemical pharmacology
_cOct 1969
300 _a2578-80 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcute Disease
650 0 4 _aAsparaginase
_xadministration & dosage
650 0 4 _aAsparagine
_xisolation & purification
650 0 4 _aAspartic Acid
650 0 4 _aCarbon Isotopes
650 0 4 _aChromatography
650 0 4 _aChronic Disease
650 0 4 _aEscherichia coli
_xenzymology
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aLeukemia, Lymphoid
_xdrug therapy
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aLeukemia, Myeloid, Acute
_xdrug therapy
650 0 4 _aLigases
_xbiosynthesis
650 0 4 _aTime Factors
700 1 _aCanellos, G P
773 0 _tBiochemical pharmacology
_gvol. 18
_gno. 10
_gp. 2578-80
856 4 0 _uhttps://doi.org/10.1016/0006-2952(69)90375-x
_zAvailable from publisher's website
999 _c4937838
_d4937838